BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma
- Authors:
- Hongxin Cao
- Shuang Quan
- Lu Zhang
- Yunzhen Chen
- Guangjun Jiao
-
Affiliations: Department of Medical Oncology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Orthopedics, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China - Published online on: March 18, 2021 https://doi.org/10.3892/ol.2021.12652
- Article Number: 391
-
Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Hameed M and Mandelker D: Tumor syndromes predisposing to osteosarcoma. Adv Anat Pathol. 25:217–222. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P and Kaghazian M: Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 18:1582018. View Article : Google Scholar : PubMed/NCBI | |
|
Harrison DJ, Geller DS, Gill JD, Lewis VO and Gorlick R: Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Harting MT and Blakely ML: Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg. 15:25–29. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Carrle D and Bielack S: Osteosarcoma lung metastases detection and principles of multimodal therapy. Cancer Treat Res. 152:165–184. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Meyers PA, Healey JH, Chou AJ, Wexler LH, Merola PR, Morris CD, Laquaglia MP, Kellick MG, Abramson SJ and Gorlick R: Addition of pamidronate to chemotherapy for the treatment of osteosarcoma. Cancer. 117:2011. View Article : Google Scholar | |
|
Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, Epidemiology, and end results program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Locy H, de Mey S, de Mey W, De Ridder M, Thielemans K and Maenhout SK: Maenhout, Immunomodulation of the tumor microenvironment: Turn Foe into friend. Front Immunol. 9:29092018. View Article : Google Scholar : PubMed/NCBI | |
|
Dumauthioz N, Labiano S and Romero P: Tumor resident memory T cells: New players in immune surveillance and therapy. Front Immunol. 9:20762018. View Article : Google Scholar : PubMed/NCBI | |
|
Blanc C, Hans S, Tran T, Granier C, Saldman A, Anson M, Oudard S and Tartour E: Targeting resident memory T cells for cancer immunotherapy. Front Immunol. 9:17222018. View Article : Google Scholar : PubMed/NCBI | |
|
Gajewski TF, Schreiber H and Fu YX: Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 14:1014–1022. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schreiber RD, Old LJ and Smyth MJ: Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lussier DM, O'Neill L, Nieves LM, McAfee MS, Holechek SA, Collins AW, Dickman P, Jacobsen J, Hingorani P and Blattman JN: Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions. J Immunother. 38:96–106. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shen JK, Cote GM, Choy E, Yang P, Harmon D, Schwab J, Nielsen GP, Chebib I, Ferrone S, Wang X, et al: Programmed cell death ligand 1 expression in osteosarcoma. Cancer Immunol Res. 2:690–698. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Beppu H, Mwizerwa ON, Beppu Y, Dattwyler MP, Lauwers GY, Bloch KD and Goldstein AM: Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene. 27:1063–1070. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP and Kim SJ: Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res. 64:7355–7360. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK. Gastroenterology. 147:196–208 e113. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Ren T, Huang Y, Bao X, Sun K, Shen D and Guo W: BMPR2 and HIF1-α overexpression in resected osteosarcoma correlates with distant metastasis and patient survival. Chin J Cancer Res. 29:447–454. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Martínez VG, Rubio C, Martínez-Fernández M, Segovia C, López-Calderón F, Garín MI, Teijeira A, Munera-Maravilla E, Varas A, Sacedón R, et al: BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer. Clin Cancer Res. 23:7388–7399. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et al: miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kuijjer ML, Rydbeck H, Kresse SH, Buddingh EP, Lid AB, Roelofs H, Bürger H, Myklebost O, Hogendoorn PC, Meza-Zepeda LA and Cleton-Jansen AM: Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes Chromosomes Cancer. 51:696–706. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi E, Masuda M, Nakayama R, Ichikawa H, Satow R, Shitashige M, Honda K, Yamaguchi U, Shoji A, Tochigi N, et al: Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma. Mol Cancer Ther. 9:535–544. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schafer W: Rhabdomyosarcoma vs normal muscle. R2 database. 2000-01-01 ed., 2000. p. Available on R2 since: 2000-01-01. | |
|
Huvos AG, Rosen G and Marcove RC: Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 101:14–18. 1977.PubMed/NCBI | |
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Siemers NO, Holloway JL, Chang H, Chasalow SD, Ross-MacDonald PB, Voliva CF and Szustakowski JD: Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors. PLoS One. 12:e01797262017. View Article : Google Scholar : PubMed/NCBI | |
|
Danaher P, Warren S, Dennis L, D'Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J and Fling SP: Gene expression markers of tumor Infiltrating leukocytes. J Immunother Cancer. 5:182017. View Article : Google Scholar : PubMed/NCBI | |
|
Sousa S and Maatta J: The role of tumour-associated macrophages in bone metastasis. J Bone Oncol. 5:135–138. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al: The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 21:938–945. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
R Core Team, . R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria: 2012, ISBN 3-900051-07-0, URL. http://www.R-project.org/ | |
|
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bami M, Mavrogenis AF, Angelini A, Milonaki M, Mitsiokapa E, Stamoulis D and Soucacos PN: Bone morphogenetic protein signaling in musculoskeletal cancer. J Cancer Res Clin Oncol. 142:2061–2072. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel PM and Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 3:807–821. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim S and Morton RA: Morton: Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene. 23:7651–7659. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Heymann MF, Lézot F and Heymann D: The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. Cell Immunol. 343:1037112019. View Article : Google Scholar : PubMed/NCBI | |
|
Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, et al: Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 4:e9985382015. View Article : Google Scholar : PubMed/NCBI | |
|
Speiser DE, Utzschneider DT, Oberle SG, Münz C, Romero P and Zehn D: T cell differentiation in chronic infection and cancer: Functional adaptation or exhaustion? Nat Rev Immunol. 14:768–774. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mittal R, Chen CW, Lyons JD, Margoles LM, Liang Z, Coopersmith CM and Ford ML: Murine lung cancer induces generalized T-cell exhaustion. J Surg Res. 195:541–549. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baitsch L, Baumgaertner P, Devêvre E, Raghav SK, Legat A, Barba L, Wieckowski S, Bouzourene H, Deplancke B, Romero P, et al: Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients. J Clin Invest. 121:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Japp AS, Kursunel MA, Meier S, Mälzer JN, Li X, Rahman NA, Jekabsons W, Krause H, Magheli A, Klopf C, et al: Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 64:1487–1494. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng W, Xiao H, Liu H and Zhou Y: Expression of programmed death 1 is correlated with progression of osteosarcoma. APMIS. 123:102–107. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fritzsching B, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Bosch AL, et al: CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: A multicenter validated retrospective study. Oncoimmunology. 4:e9908002015. View Article : Google Scholar : PubMed/NCBI | |
|
Qian BZ and Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell. 141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dumars C, Ngyuen JM, Gaultier A, Lanel R, Corradini N, Gouin F, Heymann D and Heymann MF: Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget. 7:78343–78354. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Zheng JH, Lin ZH, Lv HY, Ye ZM, Chen YP and Zhang XY: Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Aging (Albany NY). 12:3486–3501. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Eixarch H, Calvo-Barreiro L, Montalban X and Espejo C: Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation. Brain Behav Immun. 68:1–10. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Singla DK, Singla R and Wang J: BMP-7 treatment increases M2 macrophage differentiation and reduces inflammation and plaque formation in Apo E-/- mice. PLoS One. 11:e01478972016. View Article : Google Scholar : PubMed/NCBI | |
|
Limmer A and Wirtz DC: Osteoimmunology: Influence of the immune system on bone regeneration and consumption. Z Orthop Unfall. 155:273–280. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kuczma M, Kurczewska A and Kraj P: Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy. J Immunotoxicol. 11:319–327. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Browning LM, Pietrzak M, Kuczma M, Simms CP, Kurczewska A, Refugia JM, Lowery DJ, Rempala G, Gutkin D, Ignatowicz L, et al: TGF-β-mediated enhancement of TH17 cell generation is inhibited by bone morphogenetic protein receptor 1α signaling. Sci Signal. 11:eaar21252018. View Article : Google Scholar : PubMed/NCBI | |
|
Huse K, Bakkebø M, Oksvold MP, Forfang L, Hilden VI, Stokke T, Smeland EB and Myklebust JH: Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: Differential effects of BMP-6 and BMP-7. Eur J Immunol. 41:3135–3145. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gámez B, Rodriguez-Carballo E and Ventura F: BMP signaling in telencephalic neural cell specification and maturation. Front Cell Neurosci. 7:872013. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar S, Boehm J and Lee JC: p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2:717–726. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Liang X, Wang L, Wang M, Liu Z, Liu X, Zhang B, Liu E and Li G: MicroRNA-124 inhibits macrophage cell apoptosis via targeting p38/MAPK signaling pathway in atherosclerosis development. Aging (Albany NY). 12:13005–13022. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Velez-Delgado A, Mathew E, Li D, Mendez FM, Flannagan K, Rhim AD, Simeone DM, Beatty GL and Pasca di Magliano M: Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 66:124–136. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu M, Chen X, Lou J, Zhang S, Zhang X, Huang L, Sun R, Huang P, Wang F and Pan S: TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment. Oncotarget. 7:44534–44544. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liao P, Song K, Zhu Z, Liu Z, Zhang W, Li W, Hu J, Hu Q, Chen C, Chen B, et al: Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8(+) T cells and inhibiting tumor AKT/MAPK pathway. Clin Pharmacol Ther. 108:606–615. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ngan HL, Liu Y, Fong AY, Poon PHY, Yeung CK, Chan SSM, Lau A, Piao W, Li H, Tse JSW, et al: MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling. Life Sci Alliance. 3:e2019005452020. View Article : Google Scholar : PubMed/NCBI | |
|
Pousada G, Baloira A and Valverde D: Methylation analysis of the BMPR2 gene promoter region in patients with pulmonary arterial hypertension. Arch Bronconeumol. 52:293–298. 2016.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI | |
|
Liu D, Yan Y, Chen JW, Yuan P, Wang XJ, Jiang R, Wang L, Zhao QH, Wu WH, Simonneau G, et al: Hypermethylation of BMPR2 promoter occurs in patients with heritable pulmonary arterial hypertension and inhibits BMPR2 expression. Am J Respir Crit Care Med. 196:925–928. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, et al: Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 9:14162018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu N, Pauciulo MW, Welch CL, Lutz KA, Coleman AW, Gonzaga-Jauregui C, Wang J, Grimes JM, Martin LJ, He H, et al: Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. Genome Med. 11:692019. View Article : Google Scholar : PubMed/NCBI | |
|
Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, et al: The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology. 134:1332–1341. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Shi J, Jiang D, Yang S, Sun Y, Wang J, Zhang X, Liu Y, Lu Y and Yang K: Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma. Int Immunopharmacol. 83:1064022020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Ren T, Jiao G, Huang Y, Bao X, Zhang F, Liu K, Zheng B, Sun K and Guo W: BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells. Oncotarget. 8:58625–58641. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 9:287–300. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI | |
|
Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et al: Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI | |
|
Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB and Lowe AW: Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology. 131:925–933. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, et al: Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67:4605–4619. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cutcliffe C, Kersey D, Huang CC, Zeng Y, Walterhouse D and Perlman EJ; Renal Tumor Committee of the Children's Oncology Group, : Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res. 11:7986–7994. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG and Kovacs G: High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer. 9:1522009. View Article : Google Scholar : PubMed/NCBI | |
|
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, et al: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 194:1639–1647. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Béné MC, De Vos J, Hernández JM, Hofmann WK, Mills KI, et al: Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol. 28:2529–2537. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 346:1937–1947. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R and Califano A: Reverse engineering of regulatory networks in human B cells. Nat Genet. 37:382–390. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Dürig J, Bug S, Klein-Hitpass L, Boes T, Jöns T, Martin-Subero JI, Harder L, Baudis M, Dührsen U and Siebert R: Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia. 21:2153–2163. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, et al: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 5:e103122010. View Article : Google Scholar : PubMed/NCBI | |
|
Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano A, et al: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 459:717–721. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR III, Allen RE, Singer MI, et al: The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA. 102:6092–6097. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Badea L, Herlea V, Dima SO, Dumitrascu T and Popescu I: Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 55:2016–2027. 2008.PubMed/NCBI | |
|
Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, et al: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 162:1151–1162. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, Finkelstein S, Michalopoulos G and Becich M: Gene expression analysis of prostate cancers. Mol Carcinog. 33:25–35. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 1:132008. View Article : Google Scholar : PubMed/NCBI | |
|
Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ and Chaganti RS: Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66:820–827. 2006. View Article : Google Scholar : PubMed/NCBI |
